Výsledky vyhledávání - "Munekazu Yamaguchi"

PERMEABILITY AND ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO

Autor: Toshio Hisatomi, Teruto Hashiguchi, Taiji Sakamoto, Munekazu Yamaguchi, Hiroki Kawano, Naoya Yoshihara, Tatsuro Ishibashi, Shozo Sonoda, Hiroto Terasaki, Makoto Shirasawa

Publikováno v: Retina. 37:179-190

To determine the effects of bevacizumab, ranibizumab, and aflibercept on the permeability and the effects of anti-vascular endothelial growth factor (VEGF) on highly polarized retinal pigment epithelial cells (RPECs) in vitro.Highly polarized RPECs w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2c2cefdad8f21e0e90f79a9c0ba88fe
https://doi.org/10.1097/iae.0000000000001117

Zobrazit plný text záznamu

Survivin-responsive conditionally replicating adenovirus for patients with advanced sarcoma demonstrated potent and long-term efficacy and high safety in a phase I clinical trial

Autor: Teruto Hashiguchi, Eriko Sumi, Nobuhiro Ijichi, Akira Shimizu, Ken-ichiro Kosai, Takashi Yoshiura, Setsuro Komiya, Yasuo Takeda, Satoshi Nagano, Masanori Nakajo, Munekazu Yamaguchi, Toshitaka Futagawa, Muneo Takatani

Publikováno v: Journal of Clinical Oncology. 38:11512-11512

11512 Background: Whereas one of oncolytic viruses (OVs), inducing selective tumor killing and systemic anti-tumor immunity, was approved by FDA in 2015, the best OV that more safely and efficiently treats intractable cancers has not been successfull

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::5ccc33d2f9ef0a729542bd00abfaa9cb
https://doi.org/10.1200/jco.2020.38.15_suppl.11512

Zobrazit plný text záznamu

Abstract CT122: Phase I study of potentially 'best-in-class' survivin-responsive conditionally replicating adenovirus for advanced sarcoma actually demonstrates potent and long-term efficacy and high safety

Autor: Toshitaka Futagawa, Setsuro Komiya, Yasuo Takeda, Masanori Nakajo, Eriko Sumi, Akira Shimizu, Takashi Yoshiura, Satoshi Nagano, Teruto Hashiguchi, Munekazu Yamaguchi, Nobuhiro Ijichi, Muneo Takatani, Ken-ichiro Kosai

Publikováno v: Cancer Research. 78:CT122-CT122

[Background] Recent approvals of oncolytic virus (OV) by FDA and EMA attract the worldwide oncologists and anticancer market. We developed the first platform technology to efficiently construct diverse types of a next-generation conditionally replica

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::61248081f3ae400889e89cd142846ff0
https://doi.org/10.1158/1538-7445.am2018-ct122

Zobrazit plný text záznamu

Akademický článek

PERMEABILITY AND ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR EFFECTS OF BEVACIZUMAB, RANIBIZUMAB, AND AFLIBERCEPT IN POLARIZED RETINAL PIGMENT EPITHELIAL LAYER IN VITRO.

Autor: NAOYA YOSHIHARA, HIROTO TERASAKI, MAKOTO SHIRASAWA, HIROKI KAWANO, SHOZO SONODA, MUNEKAZU YAMAGUCHI, TERUTO HASHIGUCHI, TOSHIO HISATOMI, TATSURO ISHIBASHI, TAIJI SAKAMOTO

Publikováno v: Retina: The Journal of Retinal & Vitreous Diseases; Jan2017, Vol. 37 Issue 1, p179-190, 12p, 1 Diagram, 6 Graphs

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání